LANNETT CO INC FDA Approval ANDA 202048

ANDA 202048

LANNETT CO INC

FDA Drug Application

Application #202048

Application Sponsors

ANDA 202048LANNETT CO INC

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL2.5MG0LETROZOLELETROZOLE

FDA Submissions

N/A; Not ApplicableORIG1AP2014-10-29

Submissions Property Types

ORIG1Null7

CDER Filings

LANNETT CO INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 202048
            [companyName] => LANNETT CO INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"LETROZOLE","activeIngredients":"LETROZOLE","strength":"2.5MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"10\/29\/2014","submission":"ORIG-1","actionType":"Approval","submissionClassification":"Not Applicable","reviewPriority":"","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2014-10-29
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.